Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAPLE study
2025-522187-32-01Phase 4Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of voclosporin in lupus nephritis (LN) and systemic lupus erythematosus (SLE) (4 arms), sponsored by Amsterdam University Medical Center. Planned start Dec 2025; status: authorised.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on 2025-522187-32-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522187-32-01.